Net Deals Web Search

Search results

  1. Results From The WOW.Com Content Network
  2. Oxford–AstraZeneca COVID-19 vaccine - Wikipedia

    en.wikipedia.org/wiki/Oxford–AstraZeneca_COVID...

    AstraZeneca was later criticised for refusing to provide details about potentially serious neurological side effects in two trial participants who had received the experimental vaccine in the UK. While the trials resumed in the UK, Brazil, South Africa, Japan [111] and India, the US did not resume clinical trials of the vaccine until 23 October ...

  3. COVID-19 vaccination in India - Wikipedia

    en.wikipedia.org/wiki/COVID-19_vaccination_in_India

    According to India's Union Ministry of Health and Family Welfare, the most common side-effects include pain or swelling at the injection site, fever, irritability and headaches. The UK Government also lists fatigue, nausea and joint pain as common side-effects of the Oxford vaccine (known as Covishield in India). [204]

  4. AstraZeneca - Wikipedia

    en.wikipedia.org/wiki/AstraZeneca

    In January 2021, India approved the use of the Oxford–AstraZeneca vaccine, paving the way for a mass immunisation campaign in the world's second most populous country. It was announced that the Oxford–AstraZeneca shot would be made locally by the Serum Institute of India (SII) with a brand name COVISHIELD. Side-effects

  5. India's Serum says made 40 million doses of AstraZeneca's ...

    www.aol.com/news/indias-serum-says-produced-40...

    Serum Institute of India, the world's largest vaccine producer, said on Thursday it has made 40 million doses of AstraZeneca's potential COVID-19 vaccine, and would soon begin making Novavax's ...

  6. AstraZeneca to withdraw COVID vaccine globally as ... - AOL

    www.aol.com/news/astrazeneca-withdraw-covid-19...

    The Serum Institute of India (SII), which produced AstraZeneca's COVID-19 vaccine under the brand name Covishield, stopped manufacturing and supply of the doses since December 2021, an SII ...

  7. Exclusive: India delays big exports of AstraZeneca shot, as ...

    www.aol.com/news/exclusive-india-delays-big...

    India has put a temporary hold on all major exports of the AstraZeneca coronavirus shot made by the Serum Institute of India (SII), the world's biggest vaccine-maker, to meet domestic demand as ...

  8. Covaxin - Wikipedia

    en.wikipedia.org/wiki/Covaxin

    The trial also aims to assess the vaccine as a booster after other Covid vaccines used in the US. Ocugen paused Covaxin's bridging trial in April 2022 citing WHO inspection results. Phase IV trials. In June 2021, Bharat Biotech announced the start of phase IV trials to evaluate the vaccine's real-world effectiveness.

  9. These Are the Most Common Side Effects of the Omicron ... - AOL

    www.aol.com/most-common-side-effects-omicron...

    The bivalent Omicron COVID-19 booster’s side effects are similar to that of the original vaccine series, and include fever, fatigue, and muscle pain. These Are the Most Common Side Effects of ...